Pfizer and BioNTech said Wednesday that initial lab tests show that the omicron variant partly escapes protection offered by the companies' two-dose regimen of their COVID-19 vaccine. However, those ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

Vermont has opened registration to those 80 and older who are eligible for a booster shot of Pfizer’s COVID-19 vaccine. The state’s announcement on Thursday came hours after an advisory group within ...

Pfizer Inc. and BioNTech SE have announced that initial lab studies show a third dose of their Covid-19 vaccine neutralizes the Omicron variant. These results come as great news amid fears of a new ...

WASHINGTON — Pfizer and Moderna say the Food and Drug Administration have opened up COVID-19 booster shots to all adults, letting them choose another dose of either vaccine. The move expands the ...

Pfizer and BioNTech said Monday they have submitted early stage clinical trial data to the Food and Drug Administration as part of their U.S. application seeking authorization of a Covid vaccine ...

Pfizer on Monday announced it submitted data to the Food and Drug Administration regarding the results of Phase 1 trials for a potential COVID-19 vaccine booster shot. In a press release, Pfizer said ...

WASHINGTON -- The Biden administration purchased an additional 200 million doses of Pfizer-BioNTech's COVID-19 vaccine to prepare for potential additional vaccine needs in the US, an administration ...

Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...

The U.S. Food and Drug Administration has authorized booster shots of the Moderna and Pfizer COVID-19 vaccines for all adults ages 18 and older. On Friday, the FDA announced it had amended the ...